Changeflow GovPing Healthcare & Life Sciences Effect of Non-pharmacological Intervention on E...
Routine Notice Added Final

Effect of Non-pharmacological Intervention on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

The NIH registered clinical trial NCT07544186, a randomized controlled study evaluating the effect of nutritional therapy combined with L-citrulline supplementation and pulmonary rehabilitation on endothelial function, body composition, and physical capacity in recovered COVID-19 patients. The intervention group receives 4g daily L-citrulline for 3 months plus pulmonary rehabilitation, compared against a control group receiving conventional treatment and pulmonary rehabilitation alone. The study includes an interim review session at 1.5 months and requires subjects to maintain supplement intake records.

“This study aims to evaluate the impact of a non-pharmacological treatment (nutritional therapy and pulmonary rehabilitation) on endothelial function, body composition, and physical functionality in recovered COVID-19 patients.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 667 changes logged to date.

What changed

This document registers a new clinical trial on ClinicalTrials.gov, describing a randomized controlled study examining the impact of non-pharmacological interventions on recovered COVID-19 patients. The study assigns subjects to receive either nutritional therapy with L-citrulline supplementation or conventional medical management, with both groups undergoing pulmonary rehabilitation. Key parameters include a 4g daily L-citrulline dosage, a 3-month treatment duration, and an interim review at 1.5 months.

Healthcare providers and clinical investigators involved in post-COVID care or rehabilitation research may find this trial relevant for understanding emerging non-pharmacological treatment approaches. The study's focus on endothelial function, body composition, and physical functionality addresses common post-acute sequelae of COVID-19.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Effect of a Non-pharmacological Intervention on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients.

N/A NCT07544186 Kind: NA Apr 22, 2026

Abstract

This study aims to evaluate the impact of a non-pharmacological treatment (nutritional therapy and pulmonary rehabilitation) on endothelial function, body composition, and physical functionality in recovered COVID-19 patients.

The primary research question is: What is the effect of a non-pharmacological treatment (nutritional therapy and pulmonary rehabilitation) on endothelial function, body composition, and physical capacity in recovered COVID-19 patients, compared to those receiving conventional medical management? A nutritional treatment combined with L-citrulline supplementation (intervention group) will be compared against conventional treatment alone (control group). Both groups will undergo pulmonary rehabilitation for a 3-month follow-up.

Subjects assigned to the intervention group will be required to:

  • Take 4 g of L-citrulline daily for 3 months.
  • Attend an interim session at 1.5 months for review of the nutritional treatment and supplementation.
  • Keep a record of each supplement intake.

Conditions: Supplemental Nutrition Assistance Program Education, Post COVID Syndrome, Endothelial Function

Interventions: L-citrulline supplementation

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07544186

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Nutritional supplement research COVID-19 recovery study
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!